<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2024.126007</article-id><article-id pub-id-type="publisher-id">JBM-133744</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Molecular Detection of Resistance and Virulence Genes in Coagulase Negative Staphylococci Isolated from Blood Cultures at the University Teaching Hospital of Bouake
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oby</surname><given-names>Z&amp;#233;phirin Wayoro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahou</surname><given-names>Micheline N&amp;#8217;Guessan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adjaratou</surname><given-names>Traore</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Akissi</surname><given-names>Christine Houssou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Etil&amp;#233;</surname><given-names>Augustin Anoh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoulaye</surname><given-names>Diarrassouba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Safiatou</surname><given-names>Karidioula</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Juste</surname><given-names>Olivier Tadet</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pac&amp;#244;me</surname><given-names>Monemo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chantal</surname><given-names>Akoua-Koffi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Centre Hospitalier et Universitaire (CHU) de Bouak&amp;amp;#233;, Laboratoire de Bact&amp;amp;#233;riologie-Virologie, Bouak&amp;amp;#233;, C&amp;amp;#244;te d&amp;amp;#8217;Ivoire</addr-line></aff><pub-date pub-type="epub"><day>30</day><month>05</month><year>2024</year></pub-date><volume>12</volume><issue>06</issue><fpage>52</fpage><lpage>63</lpage><history><date date-type="received"><day>29,</day>	<month>April</month>	<year>2024</year></date><date date-type="rev-recd"><day>8,</day>	<month>June</month>	<year>2024</year>	</date><date date-type="accepted"><day>11,</day>	<month>June</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  &lt;b&gt;Introduction: &lt;/b&gt;Coagulase-negative staphylococci (CoNS) are currently recognized as genuine pathogens. However, little is known about the resistance and virulence genes that explain their pathogenicity in hospitals in C&amp;#244;te d'Ivoire. The aim of this study was to contribute to the genotypic identification of resistance and virulence genes in CoNS isolated from blood cultures at the University Teaching Hospital (CHU) of Bouak&amp;#233;, in order to improve patient management. &lt;b&gt;Material and Methods:&lt;/b&gt; This was a descriptive study conducted from September to December 2023. The CoNS isolates studied came from the collection of strains isolated from blood cultures of febrile patients hospitalized or attending consultations at the CHU of Bouak&amp;#233;. The strains were analyzed using conventional simplex PCR. &lt;b&gt;Results&lt;/b&gt;: Of the 45 isolates analyzed, 46.7% carried both the &lt;i&gt;aacA-aphD &lt;/i&gt;and&lt;i&gt; tetK &lt;/i&gt;genes&lt;i&gt; and &lt;/i&gt;40% carried the &lt;i&gt;mecA&lt;/i&gt; gene. With regard to virulence genes, only the &lt;i&gt;LukS-PV&lt;/i&gt; gene was observed in &lt;i&gt;S. epidermidis and S. haemolyticus&lt;/i&gt; isolates. &lt;b&gt;Conclusion&lt;/b&gt;&lt;b&gt;:&lt;/b&gt; The&lt;i&gt; &lt;/i&gt;high prevalence of CoNS isolates carrying the &lt;i&gt;mecA&lt;/i&gt; gene and the presence of virulence genes observed in this study give cause for concern in hospitals. It is important to develop comprehensive surveillance strategies against nosocomial and multi-resistant infections at the CHU of Bouak&amp;#233;.
 
</p></abstract><kwd-group><kwd>Coagulase-Negative Staphylococcus</kwd><kwd> Gene</kwd><kwd> Multiresistance</kwd><kwd> Virulence</kwd><kwd> Bouak&amp;#233;</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Staphylococci are bacteria of the genus Staphylococcus that can cause ubiquitous infections, constituting a major public health problem in various countries around the world [<xref ref-type="bibr" rid="scirp.133744-ref1">1</xref>] . The natural reservoirs of staphylococci are humans, warm-blooded animals and the environment [<xref ref-type="bibr" rid="scirp.133744-ref2">2</xref>] . Depending on their ability to produce an enzyme called coagulase, Staphylococci are divided into Coagulase Positive and Coagulase Negative (CoNS). According to many authors, CoNS, long considered contaminants, are now recognized as genuine pathogens [<xref ref-type="bibr" rid="scirp.133744-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.133744-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.133744-ref4">4</xref>] . In particular, their pathogenic power is well established in bacteremia, in immuno-depressed patients following surgery or the insertion of intra-vascular devices (bone or cardiac prostheses, probes, catheters, etc). Vascular catheters are the main entry point for these bacteremias [<xref ref-type="bibr" rid="scirp.133744-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.133744-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.133744-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.133744-ref7">7</xref>] . The morbidity associated with nosocomial CoNS bacteremia results in prolonged hospital stays [<xref ref-type="bibr" rid="scirp.133744-ref8">8</xref>] and an attributable mortality rate that varies from 10 to 30% depending on the study [<xref ref-type="bibr" rid="scirp.133744-ref9">9</xref>] . This high morbidity and prolonged hospital stay suggest the existence of virulence factors linked to the secretion of numerous toxic and enzymatic substances and resistance to antibiotic molecules [<xref ref-type="bibr" rid="scirp.133744-ref10">10</xref>] . According to the WHO, antibiotic resistance is one of the most serious threats to global health, food security and socio-economic development today. It is a natural phenomenon, but the misuse of antibiotics in humans and animals accelerates the process, leading to longer hospital stays, higher medical expenses and increased mortality [<xref ref-type="bibr" rid="scirp.133744-ref11">11</xref>] . In current practice, the identification of CoNS species is not carried out systematically in most bacteriology laboratories. The identification of Staphylococci is focused on Staphylococcus aureus. However, given the significant pathogenic role of CoNS, there are no data on the phenotypic and genotypic characteristics of the CoNS strains circulating at the University Teaching Hospital (CHU) of Bouak&#233;. It seemed appropriate to initiate this study in order to address this concern. The aim of this study is to contribute to the phenotypic and molecular identification of resistance and virulence genes in CoNS isolated from blood cultures at CHU Bouake in order to improve patient management.</p></sec><sec id="s2"><title>2. Material and methods</title><sec id="s2_1"><title>2.1. Type, Period and Origin of Strains</title><p>This was a descriptive cross-sectional study conducted from September to December 2023. The CoNS isolates studied came from the collection of strains isolated from the blood cultures of febrile patients hospitalized or referred at the University Teaching Hospital of Bouake for bacteriological analysis. These strains were stored in cryotubes containing heart-brain broth supplemented with 15% glycerol at −80˚C. The 45 CoNS strains were phenotyped during routine analyses: Staphylococcus xylosus (n = 13); Staphylococcus haemolyticus (n = 12); Staphylococcus saprophyticus (n = 5); Staphylococcus lentus (n = 5); Staphylococcus epidermidis (n = 4); Staphylococcus capitis (n = 3); Staphylococcus chromogenes (n = 2); Staphylococcus sciuri (n = 1). Sociodemographic data and clinical information were collected from patients’ microbiological records.</p></sec><sec id="s2_2"><title>2.2. Microbiological Analyses</title><sec id="s2_2_1"><title>2.2.1. Subculturing of CoNS Isolates</title><p>The CoNS isolates were subcultured onto non-selective and selective agar plates, and incubated at 37˚C for 18 to 24 hours. The culture media used were Columbia agar (Bio-Rad, Marmes-la Coquette, France) enriched with 5% fresh sheep blood, Chapman agar (Bio-Rad, Marmes-la Coquette, France) and nutrient agar. Bacterial isolates were first grown on Columbia agar medium enriched with 5% fresh sheep blood and incubated at 37˚C for 24 hours. The strains were then cultured on Chapman medium and nutrient agar. The reference strains used for the microbiological analysis were cefoxitin-susceptible S. aureus ATCC 29213 and cefoxitin-resistant S. aureus ATCC 43300 S. aureus ATCC 43300 resistant to cefoxitin. Bacteriological analyses were carried out at the molecular biology laboratory of the CHU Bouak&#233;.</p></sec><sec id="s2_2_2"><title>2.2.2. Genomic DNA Extraction</title><p>Genomic DNA extraction was performed on the 45 bacterial strains grown on nutrient agar. Depending on the density of the culture on the agar, 10 colonies of each bacterial culture were picked and placed in Eppendorf tubes containing l ml of sterile distilled water. The contents were centrifuged for 10 minutes at 4˚C at maximum speed (13,000 g). The supernatant was discarded and the pellets recovered. Then 300 &#181;l of sterile distilled water was added and placed in a water bath at 100˚C for 10 min. Heat shock was performed by placing the extracts in a −80˚C freezer for 5 minutes. Finally, the extracts were centrifuged for 10 min at maximum speed. The supernatants were aliquoted into 1.5 ml Eppendorf tubes and stored at −20˚C and then at +4˚C for conventional PCR.</p></sec><sec id="s2_2_3"><title>2.2.3. PCR Detection of Resistance and Virulence Genes</title><p>Conventional simplex PCR using specific primers for each targeted gene (<xref ref-type="table" rid="table1">Table 1</xref>) carried out molecular detection of resistance genes (mecA, aacA-aphD, tetK and tetM) and virulence genes (LukS-PV and tst). PCR amplification was performed in a 25 &#181;l reaction mixture containing 3 &#181;l of DNA extract, 6.25 &#181;l of 2&#215; GoTaq&#174; G2 Hot Start Colorless Master Mix (Promega, Madison, USA), 1.25 μL of each forward and reverse primer (10 μM) and 13.25 μL of nuclease-free water. Amplification of all genes was performed on a thermal cycler (Applied Biosystems, Inc., CA). Cycle parameters for resistance gene amplification were as follows: initial denaturation at 94˚C for 3 min followed by 30 cycles of amplification at 94˚C for 30 s, annealing at 55˚C for 30 s and extension at 72˚C for 30s (except for the final cycle which was 4 min for the extension step) [<xref ref-type="bibr" rid="scirp.133744-ref12">12</xref>] . For the LukS-PV and tst genes, amplification was carried out according to the following programme: initial denaturation at 95˚C for 5 min followed by 40 cycles of amplification at 95&#176; for 3 s, annealing at 55˚C for 30 s and extension at 72˚C for 1 min and a final cycle with extension at 75˚C for 7 min [<xref ref-type="bibr" rid="scirp.133744-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.133744-ref14">14</xref>] . PCR products were analysed on a 1.5% agarose gel at 120 V for 50 min in 1 &#215; TBE containing GelRed&#174; 10,000 &#215; nucleic acid dye using a 100 bp DNA ladder (Promega, USA) as a size marker. The DNA fragments were visualised under UV (ultraviolet) in a FastGen/Blue Green Transilluminator DE.</p></sec></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Clinical Socio-Demographic Characteristics of Patients</title><p>Analysis of the patients’ socio-demographic characteristics showed that male patients were the most represented in 57.8% of cases, with a sex ratio of 1.37. The age groups most at risk were 0 - 15 years and 31 - 65 years, with 48.90% and 33.30% respectively. The clinical diagnosis of the patients revealed a suspicion of bacteremia with a body temperature greater than or equal to 39˚C. Patients were seen in consultations in eight clinical departments at CHU Bouake.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Primers used for PCR</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Target gene</th><th align="center" valign="middle" >Primer pair</th><th align="center" valign="middle" >Primer sequence (5’-3’)</th><th align="center" valign="middle" >Fragment size (pb)</th><th align="center" valign="middle" >Annealing at Temperature ˚C</th></tr></thead><tr><td align="center" valign="middle"  colspan="4"  >Resistance gene</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="2"  >MecA</td><td align="center" valign="middle" >mecA1</td><td align="center" valign="middle" >AAAATCGATGGTAAAGGTTGGC</td><td align="center" valign="middle"  rowspan="2"  >532</td><td align="center" valign="middle"  rowspan="8"  >55</td></tr><tr><td align="center" valign="middle" >mecA2</td><td align="center" valign="middle" >AGTTCTGCAGTACCGGATTTGC</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Tetk</td><td align="center" valign="middle" >tetk1</td><td align="center" valign="middle" >GTAGCGACAATAGGTAATAGT</td><td align="center" valign="middle"  rowspan="2"  >360</td></tr><tr><td align="center" valign="middle" >tetk2</td><td align="center" valign="middle" >GTAGTGACAATAAACCTCCTA</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >TetM</td><td align="center" valign="middle" >tetM1</td><td align="center" valign="middle" >AGTGGAGCGATTACAGAA</td><td align="center" valign="middle"  rowspan="2"  >158</td></tr><tr><td align="center" valign="middle" >tetM2</td><td align="center" valign="middle" >CATATGTCCTGGCGTGTCTA</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >aacA-aphD</td><td align="center" valign="middle" >aacA-aphD1</td><td align="center" valign="middle" >TAATCCAAGAGCAATAAGGGC</td><td align="center" valign="middle"  rowspan="2"  >227</td></tr><tr><td align="center" valign="middle" >aacA-aphD2</td><td align="center" valign="middle" >GCCACACTATCATAACCACTA</td></tr><tr><td align="center" valign="middle"  colspan="4"  >Virulence gene</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="2"  >LukS-PV</td><td align="center" valign="middle" >LukS-PV</td><td align="center" valign="middle" >GGCCTTTCCAATACAATATTGG</td><td align="center" valign="middle"  rowspan="2"  >433</td><td align="center" valign="middle"  rowspan="4"  >55</td></tr><tr><td align="center" valign="middle" >LukF-PV</td><td align="center" valign="middle" >CCCAATCAACTTCATAAATTG</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Tst</td><td align="center" valign="middle" >tst-1F</td><td align="center" valign="middle" >GAAATTTTTCATCGTAAGCCCTTTGTTG</td><td align="center" valign="middle"  rowspan="2"  >180</td></tr><tr><td align="center" valign="middle" >tst-1R</td><td align="center" valign="middle" >TTCATCAATATTTATAGGTGGTTTTTCA</td></tr></tbody></table></table-wrap></sec><sec id="s3_2"><title>3.2. Genotypic Profile of CoNS Observed in Patients and Clinical Departments</title><p>Resistance genes (mecA, aacA-aphD, tetK and tetM) and virulence genes (LuKS-PV, tst) were searched for in all the different CoNS strains (<xref ref-type="fig" rid="fig1">Figure 1</xref>). PCR data showed that the strains harboured 46.7% of the aacA-aphD genes and 40% of the mecA gene. The tetK and tetM genes were found in 46.7% and 8.89% of the strains analyzed respectively. In terms of virulence genes, only the LukS-PV gene was observed in all strains, in 6.7% of cases. More specifically, the mecA gene was present in all strains with the exception of the S. sciuri strain. Among the S. xylosus strains (n = 13), 7 strains possessed the mecA resistance gene (53.8%), followed by S. epidermidis and S. chromogenes species with 50% each. The five S. saprophyticus strains identified in the study all harboured the aacA-aphD gene (100%), followed by S. epidermidis and S. chromogenes with 75 and 50% respectively. The highest percentages of TetM genes were found in S. epidermidis (25%) and S. lentus (20%). Half of the S. epidermidis strains isolated carried the LukS-PV virulence gene. The tst gene was not detected among the CoNS species analyzed (<xref ref-type="table" rid="table2">Table 2</xref>). The 0-15 and 31-65 age groups had the highest percentage of resistance and virulence genes. The External, Internal Medicine and Paediatrics departments recorded the highest rate of resistance genes. The Luks-PV virulence gene was found in the Neurosurgery, Neurology and Paediatrics departments (<xref ref-type="table" rid="table3">Table 3</xref>).</p><disp-formula id="scirp.133744-formula15"><graphic  xlink:href="//html.scirp.org/file/7-2152588x2.png?20240607165801215"  xlink:type="simple"/></disp-formula><p>Part A-M: DNA marker (100 - 1500 pb); positive control: well 3; negative control: wells 1 and 2. PCR amplification of the MecA gene showing a single band at 532 pb (wells 8, 9, 10, 11, 12, 15, 17: MecA positive strains; wells 4, 5, 6, 7, 13, 14, 18: MecA negative strains).</p><p>Part B-M: DNA marker (100 - 1500 pb); Positive control: well 12; Negative control: well 1. PCR amplification of the aacA-aphD gene showing a single band at 227 pb (Well, 3, 4, 6, 8: aacA-aphD positive strains; well 2; 5, 9, 11, aacA-aphD negative strains).</p><p><xref ref-type="fig" rid="fig1">Figure 1</xref>. Electrophoresis of 1.5% agarose gel of CoNS MecA and aacA-aphD gene.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Resistance and virulence genes observed in different CoNS species</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="4"  >Resistance gene</th><th align="center" valign="middle" >Virulence gene</th></tr></thead><tr><td align="center" valign="middle" >MecA Gene</td><td align="center" valign="middle" >aacA-aphD Gene</td><td align="center" valign="middle" >TetK Gene</td><td align="center" valign="middle" >tetM Gene</td><td align="center" valign="middle" >LukS-PV Gene</td></tr><tr><td align="center" valign="middle" >Species identified</td><td align="center" valign="middle" >n%</td><td align="center" valign="middle" >n%</td><td align="center" valign="middle" >n%</td><td align="center" valign="middle" >n%</td><td align="center" valign="middle" >n%</td></tr><tr><td align="center" valign="middle" >S. capitis (n = 3)</td><td align="center" valign="middle" >1 (33.3)</td><td align="center" valign="middle" >1 (33.3)</td><td align="center" valign="middle" >2 (66.70)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >S. chromogenes (n = 2)</td><td align="center" valign="middle" >1 (50)</td><td align="center" valign="middle" >1 (50)</td><td align="center" valign="middle" >1 (50)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >S. epidermidis (n = 4)</td><td align="center" valign="middle" >2 (50)</td><td align="center" valign="middle" >3 (75)</td><td align="center" valign="middle" >1 (25)</td><td align="center" valign="middle" >1 (25)</td><td align="center" valign="middle" >2 (50)</td></tr><tr><td align="center" valign="middle" >S. haemolyticus (n = 12)</td><td align="center" valign="middle" >4 (33.30)</td><td align="center" valign="middle" >4 (33.3)</td><td align="center" valign="middle" >6 (50)</td><td align="center" valign="middle" >1 (8.30)</td><td align="center" valign="middle" >1 (8.30)</td></tr><tr><td align="center" valign="middle" >S. lentus (n = 5)</td><td align="center" valign="middle" >1 (20)</td><td align="center" valign="middle" >1 (20)</td><td align="center" valign="middle" >1 (20)</td><td align="center" valign="middle" >1 (20)</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >S. saprophyticus (n = 5)</td><td align="center" valign="middle" >2 (40)</td><td align="center" valign="middle" >5 (100)</td><td align="center" valign="middle" >4 (80)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >S. sciuri (n = 1)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >S. xylosus (n = 13)</td><td align="center" valign="middle" >7 (53.80)</td><td align="center" valign="middle" >6 (46.1)</td><td align="center" valign="middle" >5 (38.50)</td><td align="center" valign="middle" >1 (7.70)</td><td align="center" valign="middle" >0</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Genes searched for according to age group and clinical services</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="4"  >Resistance Gene</th><th align="center" valign="middle" >Virulence Gene</th></tr></thead><tr><td align="center" valign="middle" >mecA</td><td align="center" valign="middle" >aacA-aphD</td><td align="center" valign="middle" >TetK</td><td align="center" valign="middle" >tetM</td><td align="center" valign="middle" >LukSPV</td></tr><tr><td align="center" valign="middle" >Age group</td><td align="center" valign="middle" >n%</td><td align="center" valign="middle" >n%</td><td align="center" valign="middle" >n%</td><td align="center" valign="middle" >n%</td><td align="center" valign="middle" >n%</td></tr><tr><td align="center" valign="middle" >0 - 15 ans</td><td align="center" valign="middle" >11 (61.1)</td><td align="center" valign="middle" >12 (57.1)</td><td align="center" valign="middle" >10 (47.6)</td><td align="center" valign="middle" >2 (50)</td><td align="center" valign="middle" >1 (33.3)</td></tr><tr><td align="center" valign="middle" >16 - 25 ans</td><td align="center" valign="middle" >1 (5.6)</td><td align="center" valign="middle" >1 (4.7)</td><td align="center" valign="middle" >1 (4.8)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >26 - 30 ans</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >31 - 65 ans</td><td align="center" valign="middle" >5 (27.8)</td><td align="center" valign="middle" >8 (38)</td><td align="center" valign="middle" >9 (42.8)</td><td align="center" valign="middle" >2 (50)</td><td align="center" valign="middle" >1 (33.3)</td></tr><tr><td align="center" valign="middle" >≥66 ans</td><td align="center" valign="middle" >1 (5.6)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (4.8)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (33.3)</td></tr><tr><td align="center" valign="middle" >Clinical services</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >External (n = 4)</td><td align="center" valign="middle" >4 (100)</td><td align="center" valign="middle" >2 (50)</td><td align="center" valign="middle" >3 (75)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Internal medicine (n = 10)</td><td align="center" valign="middle" >4 (40)</td><td align="center" valign="middle" >4 (40)</td><td align="center" valign="middle" >4 (100)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Neurosurgery (n = 2)</td><td align="center" valign="middle" >1 (50)</td><td align="center" valign="middle" >2 (100)</td><td align="center" valign="middle" >2 (100)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (50)</td></tr><tr><td align="center" valign="middle" >Neurology (n = 2)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (50)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (50)</td><td align="center" valign="middle" >1 (50)</td></tr><tr><td align="center" valign="middle" >Paediatrics (n = 18)</td><td align="center" valign="middle" >7 (38.9)</td><td align="center" valign="middle" >10 (55.6)</td><td align="center" valign="middle" >7 (38.9)</td><td align="center" valign="middle" >2 (11.1)</td><td align="center" valign="middle" >1 (5.6)</td></tr><tr><td align="center" valign="middle" >Pneumo-Phthisiology (n = 1)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (100)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Intensive care (n = 4)</td><td align="center" valign="middle" >1 (25)</td><td align="center" valign="middle" >2 (50)</td><td align="center" valign="middle" >3 (75)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Medical emergencies (n = 4)</td><td align="center" valign="middle" >1 (25)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (25)</td><td align="center" valign="middle" >1 (25)</td><td align="center" valign="middle" >0</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussion</title><p>Coagulase-negative staphylococci (CoNS) were previously considered contaminants of microbiology laboratories or pathogens of low virulence. Despite their low virulence, they have invasive and destructive potential, as observed in certain cases of endocarditis on natural valves [<xref ref-type="bibr" rid="scirp.133744-ref15">15</xref>] . The virulence characteristics of these strains are not well understood. Some authors have reported that the pathogenesis of CoNS in patients is linked to the insertion of medical devices such as catheters, central venous lines, urinary catheters and cardiac valve prostheses, which cause septicaemia, bacteraemia, endocarditis and urinary tract infections [<xref ref-type="bibr" rid="scirp.133744-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.133744-ref17">17</xref>] . The aim was to contribute to the molecular identification of virulence and resistance genes in CoNS strains isolated from blood cultures, in order to improve patient management. The CoNS were isolated from blood cultures from patients seen in consultation or hospitalization at the CHU Bouak&#233;. Analysis of the epidemiological and clinical data of the patients from whom the strains were isolated showed that 57.80% of the patients were male, with a sex ratio of 1.37:1. The age group most at risk was 0-15 years in 48.9% of cases. The frequency of isolation in clinical departments was 40% in paediatric and 22.2% in internal medicine. This result corroborates that of [<xref ref-type="bibr" rid="scirp.133744-ref18">18</xref>] , in which the frequency of isolation of CoNS in blood cultures was higher in paediatric wards (47.2%), followed by medical wards (44.1%). This predominance of CoNS in the aforementioned department could be explained by the high demand for bacteriological analysis due to awareness raising by the Bacteriology department among paediatricians, and by the existence of other risk factors such as catheterisation of peripheral venous lines and the fragile immune system of newborns, as supported by [<xref ref-type="bibr" rid="scirp.133744-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.133744-ref20">20</xref>] . These results are similar to those of Gbonon in his study of the ecology and antibiotic susceptibility of bacteria isolated from maternal-foetal infections, which noted a frequency of 65.38% of CoNS from positive blood cultures [<xref ref-type="bibr" rid="scirp.133744-ref9">9</xref>] . The present study provides the first report from CHU Bouak&#233; on the frequency of the mecA gene encoding PLP2a. PLP2a, which has a low affinity for betalactam antibiotics, particularly meticillin, is not affected by these antibiotics and thus allows the bacteria to continue biosynthesising its cell wall [<xref ref-type="bibr" rid="scirp.133744-ref21">21</xref>] . The aacA-aphD gene of the Staphylococcus Tn4001 transposon is a determinant of resistance to Aminosides [<xref ref-type="bibr" rid="scirp.133744-ref22">22</xref>] . This gene specifies resistance to gentamicin, tobramycin and kanamycin. It was sought in isolates with the KTG resistance phenotype. Two main mechanisms of tetracycline resistance have been described in S. aureus: active efflux, resulting from the acquisition of the tetK and tetL genes located in the plasmid, and ribosomal protection by elongation factor-type proteins encoded by chromosomal tetM or tetO [<xref ref-type="bibr" rid="scirp.133744-ref23">23</xref>] . In this study, the primers tetK and tetM were used to search for tetracycline resistance genes in isolates. Virulence-related genes encoding Panton-Valentine leukocidin toxin (Luk-PV) and the tst gene encoding staphylococcal toxic shock toxin (tst) were also identified in the various isolates. From a total of 45 CoNS isolates, 18 (40%) carried the mecA gene. Other resistance genes such as aacA-aphD and tetM were found in 46.7% and 8.89% respectively. As for virulence genes, only the LukS-PV gene was observed in 6.7% of isolates. In light of these results, there is a discrepancy between the phenotypic detection of methicillin resistance using cefoxitin screening and the absence of the mecA gene in CoNS strains. This may be attributed to the fact that methicillin resistance is caused by mechanisms other than mecA gene expression [<xref ref-type="bibr" rid="scirp.133744-ref24">24</xref>] . Furthermore, the sensitivity of PCR in the detection of mecA may have been compromised by the presence of PCR inhibitors or other physical factors [<xref ref-type="bibr" rid="scirp.133744-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.133744-ref26">26</xref>] . Furthermore, it was observed in this study that mecA-negative isolates resistant to cefoxitin have mecA alleles that could not be detected by the primers used in this study. This is because many CoNS strains also exhibit diversity in mecA sequences and have a different impact on β-lactam resistance [<xref ref-type="bibr" rid="scirp.133744-ref25">25</xref>] . The results of work by Mohammad et al. showed that out of 15 isolates with a phenotype resistant to oxacillin or cefoxitin, only one possessed the mecA gene [<xref ref-type="bibr" rid="scirp.133744-ref27">27</xref>] . It has been noted that there are unusual methicillin-resistant CONSs that have a resistance mechanism other than PBP2a production and these have been reported as borderline methicillin-resistant strains [<xref ref-type="bibr" rid="scirp.133744-ref28">28</xref>] . Methicillin-resistant borderline strains are resistant to oxacillin due to their plasmid determinants, including hyperproduced penicillinases, genes conferring resistance to cadmium or other gene products [<xref ref-type="bibr" rid="scirp.133744-ref29">29</xref>] . It is also possible that cefoxitin-resistant mecA-negative CoNS have mecA alleles that could not be detected by the primers used in this study. Many CoNS strains also show diversity in mecA sequences and have a different impact on β-lactam resistance. The prevalence of the different genes according to CoNS species showed that S. xylosus species harboured 53.8% of the mecA gene. However, the aacA-aphD gene was present in all the S. saprophyticus species isolated and identified, and 50% of S. epidermidis species possessed the LukS-PV virulence gene, followed by 25% with the TetM gene. The LukS-PV virulence gene was most frequently observed in patients aged 0 - 15 years. The presence of multi-drug resistant CoNS in the hospital setting, presenting resistance and then virulence genes in patients of all ages and more particularly in those aged 0 - 15 years, is a major concern for clinicians. And this situation may be the main cause of failure in the treatment of infectious diseases, increased morbidity and mortality and the evolution of new pathogens.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The study of CoNS is becoming increasingly relevant, both clinically and epidemiologically, as evidenced by the number of infections, morbidity, and mortality attributed to them. Although most of them are classified as simple contaminants, they can in some cases be the cause of infections. There is a marked diversity of CoNS species at Bouak&#233; University Hospital. The CoNS are therefore a crucial aetiological agent of human infections, particularly in paediatric and intensive care units where the use of medical devices is common. This study is one of the first to demonstrate a high incidence of CoNS in blood cultures in Bouak&#233;, based on resistance and virulence genes. A high prevalence of strains carrying the mecA gene was reported in the CoNs analyzed. The presence of virulence and resistance genes observed in this study on CoNS is becoming a cause for concern in the hospital environment. It is of the utmost importance to develop comprehensive surveillance and prevention strategies that will lead to effective and robust control not only of CoNS but also of other multi-resistant infections. Key elements of these strategies include the implementation of active screening procedures tailored to the specific endemic situation, adherence to basic infection control practices, the introduction and monitoring of micro-organism-specific hygiene measures, and antibiotic control programs. The increasing availability of new-generation sequencing tools due to their falling cost has not yet been reflected in C&#244;te d’Ivoire, by their limited use in routine investigations, at least in the large microbiology laboratories. The acquisition of benchtop high-throughput sequencing equipment will be important for investigating outbreaks of CoNS infections with reduced turnaround times. This will lead to a thorough assessment of the true infectious/virulent potential of isolated CoNS species and inform rapid clinical decisions.</p></sec><sec id="s6"><title>Current State of Knowledge on the Subject</title><p>&#183; The CoNS, long considered contaminants, are now recognized as genuine pathogens;</p><p>&#183; The frequency of isolation of CoNS in blood cultures is higher in paediatrics;</p><p>&#183; The high morbidity and prolonged hospital stay suggest the existence of virulence factors linked to the secretion of numerous toxic and enzymatic substances and resistance to antibiotic molecules in CoNS.</p></sec><sec id="s7"><title>Contribution of Our Study to Knowledge</title><p>&#183; Almost half of the CoNS isolates contained the aacA-aphD, TetK and mecA genes;</p><p>&#183; The presence of CoNS virulence and resistance genes is becoming a cause for concern in hospitals, and surveillance and prevention strategies need to be introduced against CoNS and other multi-resistant bacteria.</p></sec><sec id="s8"><title>Authors’ Contributions</title><p>All authors have read and approved the final version of the manuscript.</p></sec><sec id="s9"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="s10"><title>Cite this paper</title><p>Wayoro, O.Z., N’Guessan, A.M., Traore, A., Houssou, A.C., Anoh, E.A., Diarrassouba, A., Karidioula, S., Tadet, J.O., Monemo, P. and Akoua-Koffi, C. (2024) Molecular Detection of Resistance and Virulence Genes in Coagulase Negative Staphylococci Isolated from Blood Cultures at the University Teaching Hospital of Bouake. Journal of Biosciences and Medicines, 12, 52-63. https://doi.org/10.4236/jbm.2024.126007</p></sec></body><back><ref-list><title>References</title><ref id="scirp.133744-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Freney, J., Renaud, F., Leclercq, R. and Riegel, P. (2007) Pr&amp;#233;cis de bact&amp;#233;riologie clinique. Eska,&lt;i&gt; &lt;/i&gt;Paris, 795-828.</mixed-citation></ref><ref id="scirp.133744-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Becker, K., Heilmann, C. and Peters, G. (2014) Coagulase Negative Staphylococci. &lt;i&gt;Clinical Microbiology Reviews&lt;/i&gt;, 27, 870-926. &lt;br&gt;https://doi.org/10.1128/CMR.00109-13</mixed-citation></ref><ref id="scirp.133744-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Van Boeckel, T.P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B.T., Levin, S.A. and Laxminarayan, R. (2014) Global Antibiotic Consumption 2000 to 2010: An Analysis of National Pharmaceutical Sales Data. &lt;i&gt;The Lancet Infectious Diseases&lt;/i&gt;, 14, 742-750. &lt;br&gt;https://doi.org/10.1016/S1473-3099(14)70780-7</mixed-citation></ref><ref id="scirp.133744-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Valencia-Rey, P., Weinberg, J., Miller, N.S. and Barlam, T.F. (2015) Coagulase-Negative Staphylococcal Bloodstream Infections: Does Vancomycin Remain Appropriate Empiric Therapy? &lt;i&gt;Journal of Infection&lt;/i&gt;,&lt;i&gt; &lt;/i&gt;71, 53-60.&lt;br&gt;https://doi.org/10.1016/j.jinf.2015.02.007</mixed-citation></ref><ref id="scirp.133744-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Jain, R. and Danziger, L.H. (2004) Multidrug-Resistant &lt;i&gt;Acinetobacter&lt;/i&gt; Infections: An Emerging Challenge to Clinicians. &lt;i&gt;Annals of Pharmacotherapy&lt;/i&gt;, 38, 1449-1459.&lt;br&gt;https://doi.org/10.1345/aph.1D592</mixed-citation></ref><ref id="scirp.133744-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Otto, M. (2004) Virulence Factors of the Coagulase-Negative Staphylococci. &lt;i&gt;Fro&lt;/i&gt;&lt;i&gt;n&lt;/i&gt;&lt;i&gt;tiers in Bioscience&lt;/i&gt;-&lt;i&gt;Landmark&lt;/i&gt;, 9, 841-863. &lt;br&gt;https://doi.org/10.2741/1295</mixed-citation></ref><ref id="scirp.133744-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">G&amp;#246;&amp;#231;men, J.S., B&amp;#252;y&amp;#252;kko&amp;#231;ak, &amp;#220;., Azap, A., Pekuz, Y. and &amp;#199;a&amp;#287;layan, O. (2012) The Effects of Four Different Drugs Administered through Catheters on Slime Production in Coagulase Negative Staphylococci. &lt;i&gt;Journal of Microbiology and Infectious Di&lt;/i&gt;&lt;i&gt;s&lt;/i&gt;&lt;i&gt;eases&lt;/i&gt;, 2, 150-154.</mixed-citation></ref><ref id="scirp.133744-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Bertrand, X., Lallemand, S., Houverez, M., Boisson, K. and Talon, D.&lt;i&gt; &lt;/i&gt;(2002) Bacteremia Caused by Coagulase-Negative Staphylococci: Incidence, Frequency of Teicoplanin Resistance and Molecular Epidemiology. &lt;i&gt;Pathologie Biologie&lt;/i&gt;, 50, 552-559. &lt;br&gt;https://doi.org/10.1016/S0369-8114(02)00347-4</mixed-citation></ref><ref id="scirp.133744-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Gbonon, V., N&amp;#8217;Guessan, R., Guessennd, N. and Ouattara, D. (2013) Ecologie et sensibilit&amp;#233; aux antibiotiques des bact&amp;#233;ries isol&amp;#233;s d&amp;#8217;infections maternofoetale au CHU de Yopougon (Abidjan). &lt;i&gt;Rev&lt;/i&gt;&lt;i&gt;ue&lt;/i&gt;&lt;i&gt; Bio&lt;/i&gt;-&lt;i&gt;Africa&lt;/i&gt;, 12, 13-18.</mixed-citation></ref><ref id="scirp.133744-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Weinstein, M.P. (2003) Blood Culture Contamination: Persisting Problems and Partial Progress. &lt;i&gt;Journal of Clinical Microbiology&lt;/i&gt;, 41, 2275-2278.&lt;br&gt;https://doi.org/10.1128/JCM.41.6.2275-2278.2003</mixed-citation></ref><ref id="scirp.133744-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">OMS (Organisation Mondiale de la Sant&amp;#233;) (2024) R&amp;#233;sistance aux antimicrobiens.&lt;br&gt;https://www.who.int/fr/news-room/fact-sheets/detail/antimicrobial-resistance</mixed-citation></ref><ref id="scirp.133744-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Strommenger, B., Kettlitz, C., Werner, G. and Witte, W. (2003) Multiplex PCR Assay for Simultaneous Detection of Nine Clinically Relevant Antibiotic Resistance Genes in &lt;i&gt;Staphylococcus aureus&lt;/i&gt;.&lt;i&gt; J&lt;/i&gt;&lt;i&gt;ournal of Clinical Microbiology&lt;/i&gt;, 41, 4089-4094.&lt;br&gt;https://doi.org/10.1128/JCM.41.9.4089-4094.2003</mixed-citation></ref><ref id="scirp.133744-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Said-Salim, B., Mathema, B., Braughton, K., Davis, S., Sinsimer, D., Eisner, W., Likhoshvay, Y., DeLeo, F.R., Barry, N. and Kreiswirth, B.N. (2005) Differential Distribution and Expression of Panton-Valentine Leucocidin among Community-Acquired Methicillin-Resistant &lt;i&gt;Staphylococcus aureus&lt;/i&gt; Strains. &lt;i&gt;J&lt;/i&gt;&lt;i&gt;ournal of Clinical Microbiology&lt;/i&gt;, 43, 3373-3379. &lt;br&gt;https://doi.org/10.1128/JCM.43.7.3373-3379.2005</mixed-citation></ref><ref id="scirp.133744-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Touaitia, R. (2016) &lt;i&gt;Staphylococcus aureus &lt;/i&gt;r&amp;#233;sistant &amp;#224; la m&amp;#233;thicilline: Emergence et m&amp;#233;canismes de r&amp;#233;sistance. Ph.D. Thesis, Universit&amp;#233; Badji Mokhtar-Annaba, Annaba.</mixed-citation></ref><ref id="scirp.133744-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Grace, A.J., Olayinka, B.O., Onaolapo, J.A. and Stephen, S.K. (2019) &lt;i&gt;Staphylococcus aureus&lt;/i&gt; and Coagulase-Negative Staphylococci in Bacteraemia: The Epidemiology, Predisposing Factors, Pathogenicity and Antimicrobial Resistance. &lt;i&gt;Clinical Micr&lt;/i&gt;&lt;i&gt;o&lt;/i&gt;&lt;i&gt;biology&lt;/i&gt;, 8, Article No. 2. &lt;br&gt;https://doi.org/10.4172/2327-5073.1000325</mixed-citation></ref><ref id="scirp.133744-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Venkatesh, M.P., Placencia, F. and Weisman, L.E. (2006) Coagulase-Negative Staphylococcal Infections in the Neonate and Child: An Update. &lt;i&gt;Seminars in Pediatric Infectious Diseases&lt;/i&gt;, 17, 120-127. &lt;br&gt;https://doi.org/10.1053/j.spid.2006.06.005</mixed-citation></ref><ref id="scirp.133744-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Mohammad, M.A.K., Aftab, F. and Ahmad, M.A. (2014) Clinically Significant Coagulule Negative Staphylococci and Antibiotic Resistance Pattern in a Tertiary Care Hospital. &lt;i&gt;Journal of Paskistan Medical Association&lt;/i&gt;, 64, 1171-1174.</mixed-citation></ref><ref id="scirp.133744-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Houssaini, Z.E., Harrar, N., Zerouali, K., Belabbes, H. and Elmdaghri, N.I. (2019) Pr&amp;#233;valence des staphylocoques &amp;#224; coagulase n&amp;#233;gative dans les h&amp;#233;mocultures au Centre Hospitalier Universitaire Ibn Rochd de Casablanca. &lt;i&gt;Pan African Medical Journal&lt;/i&gt;,&lt;i&gt; &lt;/i&gt;33, Article No. 193. &lt;br&gt;https://doi.org/10.11604/pamj.2019.33.193.18552</mixed-citation></ref><ref id="scirp.133744-ref19"><label>19</label><mixed-citation publication-type="book" xlink:type="simple">Remington, J.S., Klein, J.O., Wilson, B.C., Nizet, V. and Maldonado, Y.A. (2011) Staphylococcal Infections. In: Remington, J.S., Klein, J.O., Wilson, C.B. and Nizet, V., Eds., &lt;i&gt;Infectious Diseases of the Fetus and Newborn&lt;/i&gt;, Saunders, Philadelphia, 489-505. &lt;br&gt;https://doi.org/10.1016/B978-1-4160-6400-8.00014-6</mixed-citation></ref><ref id="scirp.133744-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Luzzaro, F., Ortisi, G., Larosa, M., Drago, M., Brigante, G. and Gesu, G. (2011) Prevalence and Epidemiology of Microbiol Pathogens Causing Bloodstream Infectious: R&amp;#233;sultats of the OASIS Multicenter Study. &lt;i&gt;Diagnostic Microbiology and Infectious Diseases&lt;/i&gt;, 69, 363-369. &lt;br&gt;https://doi.org/10.1016/j.diagmicrobio.2010.10.016</mixed-citation></ref><ref id="scirp.133744-ref21"><label>21</label><mixed-citation publication-type="book" xlink:type="simple">Gilmore, K.S., Gilmore, M.S. and Sahm, D.F. (2008) Methicillin Resistance in &lt;i&gt;St&lt;/i&gt;&lt;i&gt;a&lt;/i&gt;&lt;i&gt;phylococcus aureus&lt;/i&gt;. In: Wax, R.G., Lewis, K., Salyers, A.A. and Taber, H., Eds., &lt;i&gt;Becterial Resistance to Antimicrobias&lt;/i&gt;, 2nd Edition, CRC Press, Boca Raton, 291-312.</mixed-citation></ref><ref id="scirp.133744-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Udou, T. (2004) Dissemination of Nosocomial Multiple-Aminoglycoside-Resistant &lt;i&gt;Staphylococus aureus&lt;/i&gt; Caused by Horizontal Transfert of the Resistance Determinant (&lt;i&gt;aacA&lt;/i&gt;/&lt;i&gt;aphD&lt;/i&gt;) and Clonal Spread of Resistant Strain. &lt;i&gt;American Journal of I&lt;/i&gt;&lt;i&gt;n&lt;/i&gt;&lt;i&gt;fection Control&lt;/i&gt;, 32, 215-219. &lt;br&gt;https://doi.org/10.1016/j.ajic.2003.11.002</mixed-citation></ref><ref id="scirp.133744-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Emaneini, M., Bigverdi, R., Kalantar, D., Soroush, S., Jabalameli, F., Khoshgnab N.B., Asadollahi, P. and Taherikalani, M. (2013) Distribution of Genes Encoding Tetracycline Resistance and Aminoglycoside Modifying Enzymes in &lt;i&gt;Staphylococcus aureus&lt;/i&gt; Strains Isolated from a Burn Center.&lt;i&gt; Annals of Burns and Fire Disasters&lt;/i&gt;,&lt;i&gt; &lt;/i&gt;2, 76-80.</mixed-citation></ref><ref id="scirp.133744-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Gradelski, E., Aleksunes, L., Valera, L., Bonner, D. and Fung-Tomc, J. (2001) Correlation between Genotype and Phenotypic Categorization of Staphylococci Based on Methicillin Susceptibility and Resistance. &lt;i&gt;Journal of Clinical Microbiology&lt;/i&gt;, 39, 2961-2963. &lt;br&gt;https://doi.org/10.1128/JCM.39.8.2961-2963.2001</mixed-citation></ref><ref id="scirp.133744-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Shrestha, N.K., Tuohy, M.J., Hall, G.S., Isada, C.M. and Procop, G.W. (2002) Rapid Identification of &lt;i&gt;Staphylococcus aureus &lt;/i&gt;and the &lt;i&gt;mecA&lt;/i&gt; Gene from BacT/ALERT Blood Culture Bottles by Using the Light Cycler System. &lt;i&gt;Journal of Clinical Micr&lt;/i&gt;&lt;i&gt;o&lt;/i&gt;&lt;i&gt;biology&lt;/i&gt;, 40, 2659-2661. &lt;br&gt;https://doi.org/10.1128/JCM.40.7.2659-2661.2002</mixed-citation></ref><ref id="scirp.133744-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Ingato, S.P., Kimang&amp;#225;, N., Omuse, G., Kariuki, S., Gunturu, R. and Dinda, V. (2014) Characteristics of Archived Coagulase Negative &lt;i&gt;Staphylococci&lt;/i&gt; Isolates at a University Hospital, Nairobi, Kenya.&lt;i&gt; Open Journal of Medical Microbiology&lt;/i&gt;, 4, 236-241. &lt;br&gt;https://doi.org/10.4236/ojmm.2014.44026</mixed-citation></ref><ref id="scirp.133744-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Han, J.E., Hwang, S.Y., Kim, J.H., Shin, S.P., Jun, J.W., Chai, J.Y., Park, Y.H. and Park, S.C. (2013) CPRMethicillin Resistant Coagulase-Negative Staphylococci Isolated from South Korean Ducks Exhibiting Tremor. &lt;i&gt;Acta Veterinaria Scandinavica&lt;/i&gt;,&lt;i&gt; &lt;/i&gt;55, Article No. 88. &lt;br&gt;https://doi.org/10.1186/1751-0147-55-88</mixed-citation></ref><ref id="scirp.133744-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Suzuki, E., Hiramatsu, K. and Yokota, T. (1999) Survey of Methicillin-Resistant Clinical Strains of Coagulase-Negative Staphylococci for &lt;i&gt;mecA&lt;/i&gt; Gene Distribution. &lt;i&gt;Antimicrobial Agents and Chemotherapy&lt;/i&gt;, 36, 429-434.&lt;br&gt;https://doi.org/10.1128/AAC.36.2.429</mixed-citation></ref><ref id="scirp.133744-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Massida, O., Mingoia, M., Fadda D., Whalen, M.B., Montanari, M.P., &lt;i&gt;et al&lt;/i&gt;. (2006) Analysis of the &amp;#946;-Lactamase Plasmid of Borderline Methicillin-Susceptible &lt;i&gt;Staphylococcus aureus&lt;/i&gt;: Focus on &lt;i&gt;bla&lt;/i&gt; Complex Genes and Cadmium Resistance Determinants &lt;i&gt;cadD&lt;/i&gt; and &lt;i&gt;cadX&lt;/i&gt;. &lt;i&gt;Plasmide&lt;/i&gt;,&lt;i&gt; &lt;/i&gt;55, 114-127.&lt;br&gt;https://doi.org/10.1016/j.plasmid.2005.08.001</mixed-citation></ref></ref-list></back></article>